Condition: HIV Infections · Sponsor: Westat
Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).
This description comes directly from the study's public registry record.
Erin Ricketts · 240-453-2786 · erinricketts@westat.com
Nancy Liu · 718-980-3937 · NancyLiu@westat.com
Always discuss trial participation with your own doctor first.
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Emory Atlanta Adolescent Consortium | Atlanta, Georgia, United States | Not Yet Recruiting |
| Johns Hopkins University | Baltimore, Maryland, United States | Not Yet Recruiting |
| St. Jude Children's Research Hospital | Memphis, Tennessee, United States | Recruiting |
| Baylor College of Medicine | Houston, Texas, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07728123